See also this year's filing and all EDGAR filings for this company.
PDF Report 0001100397_2017_Ayala_Pharmaceuticals_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001100397, Ayala Pharmaceuticals Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 159,875,198 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 4,329,121 |
| 2 | PropertyPlantAndEquipmentNet | 4,389,074 |
| 3 | remainder_Assets | 450,667 |
| 4 | LiabilitiesCurrent | 27,706,389 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 22,035,477 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 29,394,196 |
| 9 | ResearchAndDevelopmentExpense | 42,590,617 |
| 10 | remainder_Expenses | -2,287,088 |
| 11 | remainder_Revenues | 902,124 |
| 12 | remainder_NetIncome | 327,971 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 169,044,060 |
| 1 | Liabilities | 49,741,866 |
| 2 | Expenses | 69,697,725 |
| 3 | Revenues | 902,124 |
| 4 | StockholdersEquity | 119,302,194 |
| 5 | NetIncome | -68,467,630 |
| 6 | ComprehensiveNetIncome | -68,467,630 |
| 7 | BaseVar | 144,856,873 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.75 |
| 9 | EconomicCapitalRatio | 2.86 |
Edgar->Model Mapping
Feature Distribution
Change over Time
